» Authors » Yoshikazu Otsubo

Yoshikazu Otsubo

Explore the profile of Yoshikazu Otsubo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 95
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Hirono K, Hata Y, Imamura T, Tsuboi K, Takarada S, Okabe M, et al.
J Am Heart Assoc . 2024 Nov; 13(21):e035614. PMID: 39494597
Background: Left ventricular noncompaction (LVNC) is a hereditary type of cardiomyopathy characterized by prominent trabeculations. Detailed characteristics of biventricular noncompaction (BiVNC) remain unknown. This study aimed to elucidate the clinical...
2.
Hashimoto K, Hayashida T, Otsubo Y, Niida Y, Dateki S
Cureus . 2024 Sep; 16(8):e67800. PMID: 39323690
TSC2/PKD1 contiguous gene syndrome is caused by deletions involving the TSC2 and PKD1 genes that lead to tuberous sclerosis complex and autosomal dominant polycystic kidney disease. It is characterized by...
3.
Hashimoto K, Yokokawa M, Yamashita D, Yuge K, Otsubo Y
Cureus . 2023 Aug; 15(7):e42382. PMID: 37621829
Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by the deletion or mutation of the survival motor neuron 1 (SMN1) gene. The establishment of effective newborn screening...
4.
Miyamoto T, Honda Y, Izawa K, Kanazawa N, Kadowaki S, Ohnishi H, et al.
Front Immunol . 2022 Oct; 13:905960. PMID: 36211342
Purpose: Upregulation of type I interferon (IFN) signaling has been increasingly detected in inflammatory diseases. Recently, upregulation of the IFN signature has been suggested as a potential biomarker of IFN-driven...
5.
Yoshinaga M, Ishikawa S, Otsubo Y, Shida M, Hoshiko K, Yatsunami K, et al.
Pediatr Int . 2021 Jul; 63(12):1441-1450. PMID: 34237185
Background: It is well-known that a neurologically favorable outcome of out-of-hospital cardiac arrest (OHCA) is associated with the presence of bystander-initiated cardiopulmonary resuscitation (bystander CPR) and use of an automated...
6.
Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, et al.
Ann Rheum Dis . 2020 Jul; 79(11):1492-1499. PMID: 32647028
Objectives: To collect clinical information and mutation data on patients with Blau syndrome and to evaluate their prognosis. Methods: Fifty patients with mutations were analysed. The activity of each mutant...
7.
Esaki H, Otsubo Y, Sumi M, Moriuchi M, Moriuchi H
Pediatr Int . 2019 May; 61(5):522-523. PMID: 31106487
No abstract available.
8.
Mori M, Hara T, Kikuchi M, Shimizu H, Miyamoto T, Iwashima S, et al.
Sci Rep . 2018 Feb; 8(1):1994. PMID: 29386515
We compared the efficacy and safety of infliximab with intravenous immunoglobulin (IVIG), a standard therapy, in a phase 3 trial (NCT01596335) for Japanese patients with Kawasaki disease (KD) showing persistent...
9.
Otsubo Y, Hashimoto K, Kanbe T, Sumi M, Moriuchi H
PLoS One . 2017 May; 12(5):e0175082. PMID: 28531215
Background: Intrauterine inflammation has been associated with preterm birth and neonatal complications. Few reports have comprehensively investigated multiple cytokine profiles in cord blood and precisely identified surrogate markers for intrauterine...
10.
Otsubo Y, Okafuji I, Shimizu T, Nonaka F, Ikeda K, Eguchi K
Mod Rheumatol . 2014 Nov; 27(1):169-173. PMID: 25381727
Blau syndrome (BS) is an autosomal dominant autoinflammatory disease associated with NOD2 gene mutations. It is characterized by arthritis, skin rash, and uveitis. Here, we report contrasting outcomes of a...